Brevan Howard Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $119K | Buy |
18,724
+5,743
| +44% | +$36.6K | ﹤0.01% | 1685 |
|
|
2025
Q1 | $63.1K | Buy |
+12,981
| New | +$63.1K | ﹤0.01% | 1037 |
|
|
2024
Q3 | – | Sell |
-29,058
| Closed | -$198K | – | 1159 |
|
|
2024
Q2 | $198K | Buy |
+29,058
| New | +$198K | ﹤0.01% | 845 |
|
|
2023
Q4 | – | Sell |
-13,781
| Closed | -$46.9K | – | 985 |
|
|
2023
Q3 | $46.9K | Buy |
+13,781
| New | +$46.9K | ﹤0.01% | 309 |
|